ORGANIC
LETTERS
2002
Vol. 4, No. 14
2413-2416
Convergent Enantioselective Synthesis
of the Tricyclic Core of Phomactin A
Peter J. Mohr and Randall L. Halcomb*
Department of Chemistry and Biochemistry, UniVersity of Colorado,
Boulder, Colorado 80309-0215
Received May 8, 2002
ABSTRACT
The tricyclic core of phomactin A was synthesized from 6,6-dimethyl-2-cyclohexen-1-one. Key reactions include the addition of a
cyclohexenyllithium reagent to an epoxyaldehyde and a regioselective intramolecular epoxide opening to install the oxadecalin core.
The phomactins are a novel class of platelet activating factor
(PAF) antagonists that were isolated from the marine fungus
Phoma sp. in the early 1990s.1 Of the seven phomactins
isolated, phomactin A (1) is the most structurally complex
and is the only phomactin to possess a tetracyclic structure
and a hydrated furan ring (Figure 1). Although a total
core. Recently, several reports5 have also addressed the
construction of the phomactin macrocycle using transition-
metal-mediated cyclizations and ring-closing metathesis. A
Suzuki macrocyclization has also been employed toward
phomactin D,6 the only phomactin that has been synthesized
to date.7
This letter describes the synthesis of 22, a simplified
oxadecalin-dihydrofuran system found within phomactin A,
starting from 6,6-dimethyl-2-cyclohexen-1-one.8 The syn-
thetic strategy is outlined in Scheme 1. Starting from enone
2, conversion to vinyl halide 3 (M ) halogen) should be
straightforward, and it is anticipated that addition of the
corresponding organometallic reagent (M ) metal) to ep-
oxyaldehyde 4 can be realized. Intramolecular epoxide
(2) Foote, K.; Hayes, C.; Pattenden, G. Tetrahedron Lett. 1996, 37,
275.
(3) (a) Chen, D.; Wang, J.; Totah, N. J. Org. Chem. 1999, 64, 1776. (b)
Seth, P.; Totah, N. J. Org. Chem. 1999, 64, 8750. (c) Seth, P.; Totah, N.
Org. Lett. 2000, 2, 2507. (d) Seth, P.; Chen, D.; Wang, J.; Gao, X.; Totah,
N. Tetrahedron 2000, 56, 10185.
Figure 1. Structures of representative phomactins.
(4) Chemler, S. R.; Iseloh, U.; Danishefsky, S. J. Org Lett. 2001, 3, 2949.
(5) (a) Mi, B.; Maleczka, R. Org. Lett. 2001, 3, 1491. (b) Foote, K.;
John, M.; Pattenden, G. Synlett. 2001, 365. (c) Chemler, S.; Danishefsky,
S. Org. Lett. 2000, 2, 2695. (d) Houghton, T. J.; Choi, S.; Rawal, V. H.
Org. Lett. 2001, 3, 3615.
(6) Kallan, N.; Halcomb, R. Org. Lett. 2000, 2, 2687.
(7) Miyaoka, H.; Saka, Y.; Miura, S.; Yamada, Y. Tetrahedron Lett. 1996,
37, 7107.
synthesis of phomactin A has not yet been reported, there
have been several reported approaches2-4 to the oxadecalin
(1) (a) Sugano, M.; Sato, A.; Iijima, Y.; Oshima, T.; Furuya, K.; Kuwano,
H.; Hata, T.; Hanzawa, H. J. Am. Chem. Soc. 1991, 113, 5463. (b) Sugano,
M.; Sato, A.; Iijima, Y.; Furuya, K.; Haruyama, H.; Yoda, K.; Hata, T. J.
Org. Chem. 1994, 59, 564. (c) Sugano, M.; Sato, A.; Iijima, Y.; Oshima,
T.; Furuya, K.; Kuwano, H.; Hata, T. J. Antibiot. 1995, 48, 1188.
(8) Magnusson, G.; Thoren, S. J. Org. Chem. 1973, 38, 1380.
10.1021/ol026159t CCC: $22.00 © 2002 American Chemical Society
Published on Web 06/13/2002